News

NLRX1: A New Therapeutic Target for Inflammatory Bowel Disease

Read More

Landos Vision for Personalized Medicine and Health

Read More

Landos is Solving Immunology to Accelerate Drug Development

Read More

New Indications: LANCL2 in Bacterial Infections

Read More

LANCL2: A Novel Therapeutic Target for Influenza

Read More